Michele Davis Welsh Net Worth

The estimated Net Worth of Michele Davis Welsh is at least $345 Mille dollars as of 15 August 2024. Michele Welsh owns over 1,329 units of Novanta Inc stock worth over $345,356 and over the last 2 years Michele sold NOVT stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Michele Welsh NOVT stock SEC Form 4 insiders trading

Michele has made over 2 trades of the Novanta Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Michele exercised 1,329 units of NOVT stock worth $221,943 on 15 August 2024.

The largest trade Michele's ever made was exercising 1,329 units of Novanta Inc stock on 15 August 2024 worth over $221,943. On average, Michele trades about 531 units every 73 days since 2022. As of 15 August 2024 Michele still owns at least 2,068 units of Novanta Inc stock.

You can see the complete history of Michele Welsh stock trades at the bottom of the page.

What's Michele Welsh's mailing address?

Michele's mailing address filed with the SEC is C/O NOVANTA INC., 125 MIDDLESEX TURNPIKE, BEDFORD, MA, 01730.

Insiders trading at Novanta Inc

Over the last 9 years, insiders at Novanta Inc have traded over $115,059,741 worth of Novanta Inc stock. The most active insiders traders include Stephen W Bershad, Ira J Lamel e Matthijs Glastra. On average, Novanta Inc executives and independent directors trade stock every 15 days with the average trade being worth of $1,701,396. The most recent stock trade was executed by Robert Buckley on 3 September 2024, trading 4,379 units of NOVT stock currently worth $61,875.

What does Novanta Inc do?

novanta (nasdaq: novt) delivers innovations that matter for its medical and advanced industrial oem customers. if you have a passion for solving complex technical problems that lead to breakthrough performance and that enhance people's lives, come join our growing team. here is a sample of the many exciting applications we serve: • innovations that ensure the safety of patients and efficient workflows in hospitals using our novel rfid technology • innovations in additive manufacturing, also known as 3-d metal printing, using our lightning fast lasers and laser beam steering sub-systems • innovations in minimally invasive surgery using our highly reliable insufflators, pumps and visualization systems • innovations in robotics and automation using our precision motors, encoders and drives for superior accuracy • innovations in smartphone production using our fast, accurate lasers and laser beam steering equipment along with our precision motion systems the driving force behind our grow

Complete history of Michele Welsh stock trades at Novanta Inc

Novanta Inc executives and stock owners

Novanta Inc executives and other stock owners filed with the SEC include:

• Matthijs Glastra,
  Chief Executive Officer, Director
• Robert Buckley,
  Chief Financial Officer
• Matthijs Glastra,
  CEO & Chairman
• Brian Young,
  Chief Human Resource Officer
• Robert J. Buckley,
  Chief Financial Officer
• Brian S. Young,
  Chief HR Officer
• Stephen Bershad,
  Independent Chairman of the Board
• Ira Lamel,
  Independent Director
• Thomas Secor,
  Independent Director
• Brian King,
  Independent Director
• Lonny Carpenter,
  Independent Director
• Deborah Eldracher,
  Independent Director
• Ray Nash,
  Corp. Fin. Leader
• Heinrich Dreyer,
  Group Pres of Vision
• Charlie Webster,
  Exec. VP of Novanta Growth System & Global Supply Chain
• Kitty Sahin,
  Exec. VP of Strategy & Bus. Devel.
• Sarah Betadam,
  Chief Information Officer
• Peter L. Chang,
  Corp. Controller & Chief Accounting Officer
• Harry L Bosco,
  Director
• John A Roush,
  Chief Executive Officer
• Dominic A Romeo,
  Director
• Dennis J Fortino,
  Director
• Peter L Chang,
  CAO-Corporate Controller
• Frank Anders Wilson,
  Director
• Darlene J. S. Solomon,
  Director
• Mary Kay Ladone,
  Director
• Maxine Lum Mauricio,
  Director
• Katherine Ann Owen,
  Director
• Robert Matthew Johnson,
  Director
• Barbara B. Hulit,
  Director
• Michele Davis Welsh,
  General Counsel